Discover exclusive news, ideas and insights from across the spectrum of healthcare innovation.

How will you advance healthcare?

Regular

Laurie Glimcher

What's Needs to Happen to Accelerate Cancer Research and Improve Care?

Gillian Sandler is a life sciences investor who funds health tech companies that could potentially help millions of people. But her journey began with a simple desire: To find a treatment for her own sister’s autoimmune disease.

How a Passionate Investor Battles Auto-Immunity

How a Passionate Investor Battles Autoimmunity Disease

Mary Woolley

What Will It Take to Maintain America’s Leadership in Research and Technology?

Frank Discussion about Rare Diseases

Why Rare Diseases are Really Not So Rare — and What We Can Learn From Those Living with Them

Paris-based Wandercraft unveils a next generation exoskeleton to assist disabled people — part of a surge in “exo-tech” that is also raising the specter of wearable robots that could enhance everyone.

Wandercraft -- Robot-Human Hybrids Are Here

Robot-Human Hybrids Are Here

What will it take for New York City to gain a foothold as one of the world's leading life science and biotech hubs? Susan Rosenthal, MBA, Senior Vice President, Life Sciences and Healthcare at the New York City Economic Development Corporation, and Rick Lifton, MD, PhD, President of The Rockefeller University, share insights.

What does it take to make a city a Biotech hub?

Is New York City the Next Life Sciences Hub?

Uché Blackstock, MD, and Julius Johnson, DNP, RN, FNP-BC, are dedicating their lives to being "trusted messengers" to help advance health equity.

Advancing Equity & Social Justice in Healthcare

Trusted Messengers: Two Brooklyn-Bred Doctors Talk About Reducing Health Inequities

The Fight for Food Allery Cures

Seven Facts About Food Allergies That May Surprise You

Adam Aponte, MD, CEO and Chief Medical Officer of the East Harlem Council for Human Services, Inc., is committed to minimizing and ultimately eradicating health and healthcare access disparities. He offers six ways we can begin.

Adam Aponte MD

Six Steps to Reducing Health Inequities

Undeterred Capital has invested in AI for drug discovery since this early-stage venture firm launched in 2020. Today, it’s portfolio of nearly 20 companies is collectively valued at over $1 billion. Founder and managing partner Joe Wilson, MBA, shared insights on building successful life science companies, and the current state and future of AI in healthcare.

How Life Science Companies Use AI to Target Investors

Investing in AI for Drug Discovery: Capital, Data and Safety

Why is communicating science more challenging than ever? Hear about the top five challenges, according to Jeremy Abbate, Vice President and Publisher of Scientific American.

Trust & Accuracy: Science Communication & Storytelling in the 21st Century

Five Challenges Facing Science Journalists in the Post-COVID World

Can Food Cure Us?

Why Getting FRESH Might Help You Live Longer

Through his New York City-based nonprofit, Understood.org, Nathan Friedman seeks to end the stigmas surrounding neurodiversity. The first step is to raise awareness. Here are five things Friedman wants you to know.

Embracing Neurodiversity to Drive Access & Equity v2

Five Facts about Neurodiversity You Probably Didn’t Know

The year of R&D to get from pathogen identification to vaccine for the COVID-19 pandemic was too long, experts say. Their ideal timeline to is 100 days and a new mission for pandemic preparedness.

100 Days Mission for Pandemic Preparedness

Entrepreneurial researchers facing the "Valley of Death" have options for funding other than Wall Street to fuel their discoveries:  new innovation funding programs from the  the U.S. government. 

The Secret to Connecting with the Government for Funding (and It’s Free)

LEXEO successfully navigated pandemic-era financing. Here are three lessons learned for successful startup financing in a challenging climate.

Start-up Financing in a Risk-Averse Climate: 3 Lessons From the COVID Years

 Genetic engineering of dinosaurs isn't possible, yet the technology has yielded cancer therapies and just might help us travel in outer space. 

The Case for (and Against) Genetic Engineering

Biotech startups are notoriously high-risk ventures, and most of them fail. What sets apart the ones that succeed?

Five Strategies for Biotech Startup Success

Finding the right participants is often an expensive bottleneck for clinical trials sponsors and a frustration for patients. The founders of the Clinical Trial Guide share how trial sponsors can address five common patient recruitment challenges.

Five Challenges to Clinical Trials Access and Recruitment

Why is That Man Swabbing the Subway Pole?

What 5 things will it take for science to move forward in a way that is inclusive and collaborative for all, from scientists to politicians to members of communities? At the United Nations Science Summit, Cure's panel yielded five takeaways.

The Future of Science and Inclusivity: 5 Things That Need to Happen

Andrew S. Plump, MD, PhD, President of Research & Development at Takeda Pharmaceutical Company Limited, spoke with Cure about changes needed in the way we approach science to achieve cures. 

What Will It Take to Deliver Cures to Society?

Gaining access to healthcare requires more than achieving acceptance and reducing stigma for patients with mental health illnesses. 

Our Minds Are Ailing Us, What Can Be Done Now?

Easing Access to Mental Health Care

What's ahead for gene therapy? R. Nolan Townsend, MBA, co-founded LEXEO Therapeutics to focus on bringing precision genetic medicines to patients with genetic cardiovascular diseases and Alzheimer’s. He shares his perspectives on the landscape of gene therapy clinical trials, approvals and reimbursement.


Gene Therapy, Once Reserved for Rare Single-Gene Disorders, Finds a Place in Precision Medicine

In her new book "Rebel Health: A Field Guide to the Patient-Led Revolution in Medical Care"(MIT Press, 2024), Susannah Fox shares how lessons from the rare disease community have sparked a patient-led revolution for better health. Read an excerpt here.

Rebel Health by Susannah Fox

From Rare Diseases to "Rebel Health": The patient-led transformation of healthcare

Five billion years. That's how long Christopher Mason, PhD — Professor of Physiology and Biophysics at Weill Cornell Medicine and the author of The Next 500 Years —believes the Earth has before it fails to exist. At the same time, he says that humans may be among the first life forms in the universe.

The First Ones to the Party

How can AI advance healthcare? Michael Montello, MBA, GSK’s Senior Vice President for R&D Digital and Tech Tech, shares insights into the top six areas of AI’s impact on healthcare.

At the Intersection of Healthcare, Data and Tech: Leveraging AI for Good

Compared to life-threatening conditions like cancer, inflammatory and immune system diseases are understudied, yet they diseases are common and seriously affect patients' quality of life. Gregory S. Moss, Esq., Chief Corporate Strategy and Legal Officer at Evommune, a company advancing therapies for chronic inflammatory diseases, shares his insights.

Drug Development for Inflammatory Diseases Comes of Age

The inability to reproduce research results is a frequent and costly stumbling block in drug discovery. Christina Brideau, Vice President of Preclinical Pharmacology at Deerfield Discovery and Development (3DC), shared her insights with Cure on the enduring issue of research reproducibility and how to find solutions.

Research Reproducibility: A Costly Stumbling Block for Drug Discovery

Five startup companies have won the inaugural Cure Xchange Challenge: Health AI for Good. Allagi.ai, BioCurie, Deepecho, Every Cure and Oben Health will receive one-year residencies at Cure’s innovation campus in New York City along with unrestricted seed grants, mentoring, in-kind resources and support services from Cure’s partners, including Amazon Web Services, ThermoFisher and NVIDIA.

2/22/2024 CURE Xchange Challenge 343
Group: Winners and advisors
Size: 1920x1080
Photog: Fernando Colon

Five Winners of Cure Xchange Challenge: Health AI For Good Announced

With her co-founder Professor Richard Braatz, PhD, of MIT, Irene Rombel, PhD, MBA, aims to make innovative cell and gene therapies more accessible for people living with devastating rare diseases by overcoming the manufacturing dilemmas plaguing these treatments.

Cure Xchange Challenge Finalist BioCurie logo

BioCurie Logo

Spotlight On: Irene Rombel, PhD, MBA, Co-founder, BioCurie

Grant Mitchell, MD, MBA, and his co-founder are on a mission to use AI to match drugs already on the market with diseases that currently have no cure.  

Spotlight On_Grant_Mitchell_Image

Spotlight On: Grant Mitchell, MD, MBA, CEO and Co-founder of Every Cure

As an ER nurse, Kwamane Liddell, JD, MHA, BSN, encountered many low-income families whose language barriers kept them from taking advantage of nutritious food assistance programs. He realized AI could help these families successfully access not only nutrition but also medicine, housing, and even health insurance.

ThriveLink Logo

Spotlight On: Kwamane Liddell, JD, MHA, Co-founder ThriveLink (formerly Nutrible) 

Driven to help people in marginalized communities get the healthcare they deserve, Jonathan Govette and his co-founders developed an AI solution for identifying people at high risk for lung cancer, so they can get treated early — saving both money and lives.

Cure Xchange Challenge Finalist Oatmeal Health logo

Oatmeal Health Logo

Spotlight On: Oatmeal Health Co-founder Jonathan Govette

When he was a little boy, Collins “Collogh” Oghor lost his aunt to kidney failure, and now, having earned an MD, MBA, and MPH, he has developed an AI solution to help healthcare providers battle this devastating — and preventable — disease.

Cure Xchange Challenge Finalist Collogh Cares logo

Collogh Cares Logo

Spotlight On: Collogh Cares Co-founder Collins Oghor, MD, MBA, MPH

As a young radiologist in Casablanca, Morocco, Saad Slimani, MD, MS, noticed an opportunity to use AI to provide all pregnant women, regardless of socioeconomic status, with access to a simple procedure that could save their lives as well as the lives of their babies.

Cure Xchange Challenge Finalist Deepecho logo

Deepecho Logo

Spotlight On: Saad Slimani, MD, MS,  Co-founder of Deepecho

After the sudden death of his older brother from hypertension, Peter Njongwe launched a company that marries cutting-edge AI technology with friendly neighborhood barbershops. It’s an innovative approach to getting hesitant populations to embrace the healthcare they need.

Cure Xchange Challenge Finalist Oben Health logo

Oben Health 

Spotlight On: Peter Njongwe, Co-founder of Oben Health 

Through his company Allagi.ai, Alex Gavryushkin, PhD, is using AI to streamline a time-consuming process for oncologists, allowing them to devise more effective treatment plans for patients, including those with rare and hard-to-treat cancers.

Cure Xchange Challenge Finalist Allagi.ai logo

Allagi.ai

Spotlight On: Alex Gavryushkin, Founder of Allagi.ai

AI engineer Robhy Bustami grew up in a family of obstetricians. His knowledge of the challenges around access to quality maternal medicine led him to develop an ultrasound technology solution poised to improve the health of families in underserved communities worldwide.

Cure Xchange Challenge Finalist Biotics.ai logo

BioticAI

Spotlight On: Robhy Bustami, Co-founder of BioticsAI

Tony Boccanfuso, PhD, President and CEO of the University-Industry Demonstration Project (UIDP) — a membership-based organization that fosters collaboration between industry and universities to optimize research outcomes — speaks about the value of fruitful partnerships between academic institutions and companies. With an impressive 30+ year career focused on research and innovation, Boccanfuso has helped manage various initiatives between academic, government, and private sector organizations, including the National Science Foundation, National Institutes of Health, and PricewaterhouseCoopers. 

Nurturing Collaborations Between Universities and Industry

Adrianne Nickerson, MS, the co-founder and CEO of Oula, a maternity care clinic that is taking a revolutionary approach to prenatal care, childbirth, and postpartum support, is working to make a difference. Key to the Oula clinic is a multidisciplinary team where midwives play a significant role. 

How a Startup Is Revolutionizing Maternal Healthcare

Judith Absalon, MD, MPH, FIDSA, has worked at the forefront of clinical trials for game-changing vaccines for the last 15 years. She talked with Cure Cabout the satisfaction of producing a successful vaccine, lessons learned from COVID and preparing for the next pandemic.

From Pharma's Front Lines: Infectious Diseases, Vaccines and the Future

Clinical trials leave pregnant women on the sidelines. Infectious disease physician and leading vaccine developer Judith Absalon, MD, MPH, FIDSA, offers insight into issues around women in science.

Increasing Women in Science—as Clinical Research Leaders and Participants

Microsoft Chief Medical Officer David Rhew, MD, gets beyond the hype on the value of generative artificial intelligence (AI)  in healthcare today.

From Administrative Tasks to Drug Discovery, AI is Poised to Transform Healthcare

Scientific innovations can come from our most personal experiences. For Ed Damiano, PhD, the co-founder of Beta Bionics, his transformational invention began with his son’s diagnosis of type 1 diabetes and an unwavering determination to find a better way to manage the condition.

A Bionic Pancreas that Transforms Care for People with Type 1 Diabetes

Developing therapies for patients with rare diseases: a career in the Orphan Drug Revolution by Jim Geraghty, JD, MS.

Starting a Revolution in Treating Rare Diseases

What's new

Blue

Tuesday Talks: Navigating the Entrepreneurial Ecosystem 

AI & The Future of Cures

Why Your Vaginal Microbiome Can Influence Your Health Outcomes 

Tuesday Talks: What is the Cost of a Cure?

A Pioneer of Biotech Shares Secrets of his Success

Startup Lessons on Rebuilding Brains to Treat Parkinson’s

Tuesday Talks: The Future of Equitable Health

Pioneering BioCurie's Vision

Unlocking the Power of Radical Patient Advocacy

Cure Tuesday Talks How a Passionate Investor Battles Auto-Immunity header image

How a Passionate Investor Battles Autoimmune Diseases

Cure Tuesday Talks A Bold New Approach to Wellness header image

A Bold New Approach to Wellness

Cure Tuesday Talks banner image Matthieu Masselin

Exoskeletons and the Freedom to Walk Again

Cure Tuesday Talks Christopher Mason banner image

Synthetic Biology, Space and the Next 500 Years

Cure Tuesday Talks Streamlining Critical Trials header image

Streamlining Clinical Trials 

Cure Tuesday Talks Changing Lives with Mentoring in Medicine header image 

Changing Lives with Mentoring in Medicine

Cure Tuesday Talks Clinical Trial Guide header image

Clinical Trials and the Challenges Surrounding Patient Access and Recruitment

Cure Tuesday Talks Alex Zhavoronkov banner image

Learning AI for Every Step of Pharma R&D

Cure Tuesday Talks banner image Maria Luisa Pineda

Exploring Culture and Diversity in BioPharma

Cure Tuesday Talks banner image Tony Boccanfuso

Understanding the Industry and University Research Relationship

Cure Tuesday Talks Pandemic Preparedness banner image

Cure Tuesday Talks The Future of Science and Inclusivity thumbnail image

The Future of Science & Inclusivity

Cure Tuesday Talks Joe Wilson banner image

How Life Science Companies Use AI to Target Investors 

Cure Tuesday Talks Jeremy Abbate banner image

Science Communication and Storytelling in the 21st Century

Cure Tuesday Talks banner image Ed Damiano

A Father Who is Changing the Landscape for Patients with Type 1 Diabetes

Cure Tuesday Talks banner image Susan Rosenthal

How Government Helps Drive Healthcare Innovation in NYC

Cure Tuesday Talks banner image Adrianne Nickerson

How a Startup is Revolutionizing Maternal Care

Navigating the Entrepreneurial Ecosystem

Cure Tuesday Talks banner image Nolan Townsend

A Deep Dive Into Gene Therapies of the Future

Cure Tuesday Talks banner image Judith Absalon 

From Pharma’s Front Lines: Infectious Disease, Vaccines and the Future

Cure Tuesday Talks Celebrating Pride Month: The Fight Against HIV thumbnail image 

Celebrating Pride Month: Experts and Allies on the Fight Against HIV

Cure Tuesday Talks banner image Michael Montello

How GSK is Powering R&D with Data, Digital and Tech

Cure Tuesday Talks banner image Greg Moss 

What Sets Successful Biotech Companies Apart

Cure Tuesday Talks banner image Ilana Golant

The Fight for Food Allergy Cures

Cure Tuesday Talks banner image Dr. Robert Graham 

Can Food Cure Us? 

Cure Tuesday Talks banner image Gilan Megeed

Why is a Woman’s Health Overlooked?

Cure Tuesday Talks Mary Woolley banner image

How Critical is Research and Technology to the Future - and Women's Role Within It?

Cure Tuesday Talks Adam Aponte banner image

Shaping a New Future to Solve Health Inequities

Cure Tuesday Talks banner image Jim Geraghty 

How to Build a Company and Tackle the Toughest Diseases

Cure Tuesday Talks banner image Christine Brideau

The Research Reproducibility Problem and Its Impact on Drug Discovery

Cure Tuesday Talks banner image FTI Consulting Nicole Verbeeck

Innovation, Inspiration and Creativity in Healthcare Engagement

Streaming now

Cure Opens Xseed Award Applications to Support Underfunded and Underrepresented NYC Life Science Startups With Up to $500,000

Cure® Announces Five Winners of Cure Xchange Challenge: Health AI For Good

Cure Announces 10 Finalists for Cure Xchange Challenge: Health AI For Good

Wandercraft, pioneer of walking robotics, opens U.S. corporate headquarters at Cure®, New York City’s premier healthcare innovation campus

Cure® Makes Commitment with Clinton Global Initiative to Advance Healthcare Through Partnerships Acting on Pressing Global Health Challenges and Opportunities

Cure® Opens Applications To Cure Xchange Challenge Focused On “Health AI For Good”

Cure® to Host Science Summit of 78th United Nations General Assembly

Cure®, Life Science Cares New York and Science in the City Inc. Partner to Launch Life Sciences Immersion Program for New York City High School Students

Press Releases

Browse Cure's hub of insights from around the world of healthcare and technology. Featuring articles, videos, event recaps, and other diverse perspectives.

A place to Thrive

Where scientists, entrepreneurs and visionaries converge.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

Cure Events.

How Life Science Companies Use AI to Target Investors

How will you advance healthcare?

What's new

Featured

What's Needs to Happen to Accelerate Cancer Research and Improve Care?

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Press Releases

A place to Thrive

Where scientists, entrepreneurs and visionaries converge.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

Cure Events.

How Life Science Companies Use AI to Target Investors

How will you advance healthcare?

What's new

Featured

What's Needs to Happen to Accelerate Cancer Research and Improve Care?

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Press Releases

Cure Events.